Main description:

New materials and manufacturing techniques are evolving with the potential to address the challenges associated with the manufacture of medicinal products that will teach new tricks to old drugs. Nano- and microfabrication techniques include manufacturing methods such as additive manufacturing, lithography, micro-moulding, spray drying, and supercritical fluids among many others. The increasing resolution of new techniques allow researchers to produce objects with micrometric resolutions. This book follows a consecutive order, beginning with a background in the current field and limitations in the manufacturing of different pharmaceutical products, moving on the classification of each method by providing recent examples, and future prospective on a variety of traditional and new Nano and microfabrication techniques. A focus on the materials used to prepare these systems and their biocompatibility, including applied topics such as clinical applications and regulatory aspects also covered, offering the reader a holistic view of this rapidly growing field.

Contents:

1. Conducting polymers as drug release systems2. Electrospinning for drug delivery applications3. Melt-electrospinning and electrowriting for pharmaceutical and biomedical applications4. Pharmaceutical Spray Drying5. Vat photopolymerization 3D printing for drug delivery applications6. Semi-solid extrusion 3D printing for the development of dosage forms for special patient groups7. Binder-Jetting Powder bed 3D-printing for the fabrication of drug delivery systems8. 3D printing for localized cancer therapy9. 4D Printing in Pharmaceutics & Biomedical Applications10. Lithography in Drug-Delivery11. Micro-moulding and its application to drug delivery12. Supercritical Fluids: A Promising Technique in Pharmaceutics13. Microfluidics as a tool for the synthesis of advanced drug delivery systems14. Nanofluidic Technologies for Drug Screening and Drug Delivery15. Nanoparticles at the stage of clinical trials16. Nasal drug delivery systems for the treatment of diseases of the central nervous system and tuberculosis17. Regulatory aspects and barriers in using ground-breaking technologies